Trademarkia Logo

Canada

C$
ARKETAMINE
FORMALIZED

on 8 Jan 2025

Last Applicant/ Owned by

Perception Neuroscience, Inc.

230 Riverside Dr., 19DNew York, NY 10025

US

Serial Number

2140938 filed on 19th Oct 2021

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

ARKETAMINE

Trademark usage description

pharmaceuticals for the treatment of diseases in the field of neuroscience, namely, depressive symptoms in a variety of psychiatric conditions, namely Read More

Classification Information


Class [005]
Pharmaceuticals for the treatment of diseases in the field of neuroscience, namely, depressive symptoms in a variety of psychiatric conditions, namely, depression, bipolar disorder, anxiety disorders, namely, obsessive-compulsive disorder and PTSD


Classification kind code

11

Class [042]
Scientific and medical research in the field of neuroscience, namely, depressive symptoms in a variety of psychiatric conditions, namely, depression, bipolar disorder, anxiety disorders, namely, obsessive-compulsive disorder, PTSD, and concerning antidepressants; consultation related thereto; providing information about medical research


Classification kind code

11

Class [044]
Providing medical information and news in the field of neuroscience, namely, depressive symptoms in a variety of psychiatric conditions, namely, depression, bipolar disorder, anxiety disorders, namely, obsessive-compulsive disorder, PTSD, and concerning antidepressants


Classification kind code

11

Mark Details


Serial Number

2140938

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 8th Jan 2025
Search Recorded
Submitted for opposition 20
on 8th Jan 2025
Examiner's First Report
Submitted for opposition 67
on 7th Oct 2022
Agent Name Changed
Submitted for opposition 287
on 11th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 19th Oct 2021
Filed
Submitted for opposition 1
on 19th Oct 2021
Created
Submitted for opposition 31
on 19th Oct 2021
Formalized